Skip to main content
OpenTrials

Clinical trial condition

Neuroblastoma

Explore clinical trials studying Neuroblastoma. Study availability and eligibility vary by location and protocol.

355 public trials 67 recruiting studies
Refine in advanced search Browse all conditions

Neuroblastoma trial results

Active, not recruiting

Rapid Administration Pilot for Infusing Dinutuximab

NCT05421897

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • Childrens Hospital of Colorado Aurora, Colorado, United States
  • Children's Hospital of Atlanta Atlanta, Georgia, United States
  • C.S. Mott Children's Hospital Ann Arbor, Michigan, United States
View Trial Details
Active, not recruiting

Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma

NCT04301843

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • University of Alabama/Children's of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Rady Children's Hospital San Diego, California, United States
View all 29 locations
View Trial Details
Active, not recruiting

Neuroblastoma Maintenance Therapy Trial

NCT02679144

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • University of Alabama, Children's of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • UCSF Benioff Children's Hospital Oakland- Oakland, California, United States
  • Rady Children's Hospital San Diego, California, United States
View all 47 locations
View Trial Details
Active, not recruiting

Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

NCT02176967

Conditions
Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, +10 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
View all 222 locations
View Trial Details
Active, not recruiting

A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma

NCT04106219

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsy, +11 more
Locations
  • UCSF Medical Center at Mission Bay San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • University of Chicago - Comer Children's Hospital Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 17 locations
View Trial Details
Active, not recruiting

Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors

NCT04337177

Conditions
Disease Attributes, Ewing Sarcoma, Glioma, +26 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • UCSF, Mission Bay - Benioff Children's Hospital San Francisco, California, United States
  • Children's National Research Institute - Children's National Hospital Washington D.C., District of Columbia, United States
  • Children's Healthcare of Atlanta - Arthur M. Blank Hospital Atlanta, Georgia, United States
View Trial Details
Active, not recruiting

Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow

NCT03363373

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • Riley Hospital for Children Indianapolis, Indiana, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • The Hospital for Sick Children Toronto, Canada
  • Rigshospitalet Copenhagen, Denmark
View all 20 locations
View Trial Details

Related conditions